Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585637 · ClinicalTrials.gov registry record · Phase 1
Vitamin D for Chemoprevention
A Phase 1 study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 328
- Enrollment target
NCT00585637 is a Phase 1 study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 328 participants.
The verdict
NCT00585637, a Phase 1 study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 328 participants
- Enrollment target
Study Summary
This study will help us know the effects of Vitamin D pills in Blacks. The results of this study may be the first step in creating ways to prevent the risks of colon and prostate cancer. It will also help us develop ways to reduce colon cancer and prostate cancer among Blacks. This study will find out if Vitamin D pills can increase Vitamin D to healthy levels in our bodies.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DRUG Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2007-10 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585637
The ClinicalTrials.gov registry entry for NCT00585637 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00585637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585637 about?
NCT00585637 is a clinical study titled "Vitamin D for Chemoprevention". This study will help us know the effects of Vitamin D pills in Blacks. The results of this study may be the first step in creating ways to prevent the risks of colon and prostate cancer. It will also help us develop ways to reduce colon cancer and prostate cancer among Blacks. This study will find o...
What is the current status of trial NCT00585637?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 328 participants. The study started on 2007-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00585637?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D (DRUG).
Who is sponsoring clinical trial NCT00585637?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.